The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

This report provides all the information you require to better understand Nycomed and its partnering interests and activities over the past seven years. Read the full story

Nycomed, a top Norwegian pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Eurand has entered into an exclusive commercialization, license and supply agreement with Nycomed for Russia and the Commonwealth of Independent States (CIS), as well as Georgia and Mongolia.  Read the full story

An article by Kevin Grogan, PharmaTimes.  Read the full story

Nycomed US hasn't even been born yet, and it's already promising big growth. Read the full story

Following Takeda's acquisition of Nycomed, its US dermatology subsidiary has announced it will become an independent entity. Read the full story

The business press is buzzing this morning with word that Japan's acquisitive Takeda is in talks to buy Nycomed for up to $14 billion. Read the full story

Nycomed execs are following their Big Pharma brethren in promising big growth in emerging markets Read the full story

Nycomed is expanding its presence in Latin America and buying Laboratorios Farmacol, a Colombian pharmaceutical company with a strong presence in gastroenterology, respiratory disease and gynaecology. Read the full story